Credit Agricole’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.21M | Sell |
22,985
-53,790
| -70% | -$9.91M | 0.01% | 646 |
|
|
2025
Q4 | $13.5M | Buy |
76,775
+39,323
| +105% | +$6.42M | 0.03% | 362 |
|
|
2025
Q3 | $5.25M | Buy |
+37,452
| New | +$5.06M | 0.01% | 550 |
|
|
2025
Q1 | $5.52M | Buy |
40,323
+3,859
| +11% | +$552K | 0.02% | 520 |
|
|
2024
Q4 | $5.58M | Buy |
36,464
+7,434
| +26% | +$1.25M | 0.02% | 528 |
|
|
2024
Q3 | $5.63M | Sell |
29,030
-4,782
| -14% | -$1M | 0.02% | 397 |
|
|
2024
Q2 | $7.84M | Buy |
33,812
+22,487
| +199% | +$4.89M | 0.04% | 286 |
|
|
2024
Q1 | $2.16M | Buy |
11,325
+5,790
| +105% | +$1.36M | 0.02% | 392 |
|
|
2023
Q4 | $1.43M | Buy |
5,535
+2,845
| +106% | +$699K | 0.02% | 359 |
|
|
2023
Q3 | $691K | Buy |
2,690
+60
| +2% | +$16K | 0.01% | 378 |
|
|
2023
Q2 | $749K | Buy |
2,630
+2,390
| +996% | +$711K | 0.01% | 332 |
|
|
2023
Q1 | $66.7K | Sell |
240
-1,695
| -88% | -$469K | ﹤0.01% | 479 |
|
|
2022
Q4 | $536K | Buy |
1,935
+1,695
| +706% | +$479K | 0.01% | 339 |
|
|
2022
Q3 | $64K | Sell |
240
-482
| -67% | -$102K | ﹤0.01% | 494 |
|
|
2022
Q2 | $147K | Sell |
722
-595
| -45% | -$122K | ﹤0.01% | 436 |
|
|
2022
Q1 | $278K | Buy |
1,317
+710
| +117% | +$154K | ﹤0.01% | 390 |
|
|
2021
Q4 | $146K | Buy |
607
+257
| +73% | +$66.1K | ﹤0.01% | 439 |
|
|
2021
Q3 | $99K | Buy |
350
+136
| +64% | +$44.6K | ﹤0.01% | 446 |
|
|
2021
Q2 | $74K | Sell |
214
-286
| -57% | -$86.6K | ﹤0.01% | 453 |
|
|
2021
Q1 | $140K | Buy |
500
+300
| +150% | +$80.9K | ﹤0.01% | 364 |
|
|
2020
Q4 | $49K | Hold |
200
| – | – | ﹤0.01% | 396 |
|
|
2020
Q3 | $57K | Buy |
200
+49
| +32% | +$13.7K | ﹤0.01% | 356 |
|
|
2020
Q2 | $40K | Sell |
151
-3,132
| -95% | -$941K | ﹤0.01% | 336 |
|
|
2020
Q1 | $1.04M | Sell |
3,283
-5,272
| -62% | -$1.6M | 0.09% | 151 |
|
|
2019
Q4 | $2.54M | Sell |
8,555
-10,543
| -55% | -$2.93M | 0.14% | 118 |
|
|
2019
Q3 | $4.45M | Buy |
19,098
+958
| +5% | +$223K | 0.22% | 102 |
|
|
2019
Q2 | $4.24M | Buy |
18,140
+557
| +3% | +$129K | 0.23% | 100 |
|
|
2019
Q1 | $4.16M | Buy |
17,583
+3,855
| +28% | +$1.21M | 0.23% | 111 |
|
|
2018
Q4 | $4.13M | Buy |
13,728
+650
| +5% | +$207K | 0.23% | 117 |
|
|
2018
Q3 | $4.62M | Sell |
13,078
-16,700
| -56% | -$5.75M | 0.22% | 124 |
|
|
2018
Q2 | $8.64M | Buy |
29,778
+5,180
| +21% | +$1.46M | 0.61% | 34 |
|
|
2018
Q1 | $6.74M | Buy |
24,598
+2,750
| +13% | +$854K | 0.46% | 49 |
|
|
2017
Q4 | $6.96M | Sell |
21,848
-153,951
| -88% | -$49.4M | 0.47% | 47 |
|
|
2017
Q3 | $55M | Sell |
175,799
-52,323
| -23% | -$15.5M | 0.19% | 132 |
|
|
2017
Q2 | $61.9M | Sell |
228,122
-11,801
| -5% | -$3.12M | 0.2% | 123 |
|
|
2017
Q1 | $65.6M | Sell |
239,923
-1,697
| -0.7% | -$480K | 0.2% | 125 |
|
|
2016
Q4 | $68.5M | Sell |
241,620
-27,991
| -10% | -$8.3M | 0.22% | 104 |
|
|
2016
Q3 | $84.4M | Buy |
269,611
+3,183
| +1% | +$943K | 0.27% | 79 |
|
|
2016
Q2 | $64.4M | Buy |
266,428
+3,310
| +1% | +$872K | 0.25% | 91 |
|
|
2016
Q1 | $68.5M | Sell |
263,118
-18,307
| -7% | -$4.84M | 0.32% | 66 |
|
|
2015
Q4 | $86.2M | Buy |
281,425
+108,655
| +63% | +$31.2M | 0.4% | 49 |
|
|
2015
Q3 | $50.4M | Sell |
172,770
-60,803
| -26% | -$20.1M | 0.25% | 82 |
|
|
2015
Q2 | $94.4M | Sell |
233,573
-14,272
| -6% | -$5.73M | 0.44% | 44 |
|
|
2015
Q1 | $105M | Buy |
247,845
+44,451
| +22% | +$17.5M | 0.47% | 40 |
|
|
2014
Q4 | $71.8M | Buy |
203,394
+8,075
| +4% | +$2.61M | 0.31% | 71 |
|
|
2014
Q3 | $64.6M | Buy |
195,319
+16,308
| +9% | +$5.38M | 0.28% | 83 |
|
|
2014
Q2 | $56.4M | Buy |
179,011
+23,249
| +15% | +$7M | 0.24% | 95 |
|
|
2014
Q1 | $47.6M | Buy |
155,762
+78,383
| +101% | +$24.9M | 0.19% | 140 |
|
|
2013
Q4 | $21.6M | Sell |
77,379
-10,059
| -12% | -$2.6M | 0.09% | 278 |
|
|
2013
Q3 | $21.1M | Buy |
+87,438
| New | +$19.6M | 0.09% | 276 |
|
Other funds holding BIIB
VCM
VPM
Credit Agricole's BIIB Position: Q1 2026 in Review
Credit Agricole reduced its Biogen (BIIB) stake by 70% in Q1 2026, selling an estimated $9.91M and leaving 22,985 shares worth $4.21M. The position accounts for 0.01% of the portfolio, ranked #646.
Credit Agricole first reported a position in BIIB in Q3 2013 and has held it in 50 quarters since. The position peaked at $105M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Credit Agricole held 22,985 shares of Biogen worth $4.21M as of Q1 2026.
- Credit Agricole sold 53,790 Biogen shares in Q1 2026, an estimated $9.91M.
- Biogen made up 0.01% of Credit Agricole's portfolio in Q1 2026, its #646 holding.
- Credit Agricole first reported a position in Biogen in Q3 2013 and has held it in 50 quarters since.
- Credit Agricole's Biogen position peaked at $105M in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.